Related Experiment Video

Updated: Sep 20, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.4K

Recent advances in understanding the role of HES6 in cancers

Imène Krossa1,2, Thomas Strub1,2, Arnaud Martel1,3

  • 1Université Côte d'Azur, France.

Theranostics
|June 8, 2022
PubMed

Insights

The NOTCH pathway regulates cell processes and is implicated in cancers. This review focuses on HES6, a key NOTCH component, and its role in uveal melanoma, exploring therapeutic targeting strategies.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • NOTCH signaling is crucial for embryonic development and tissue homeostasis.
  • Dysregulation of NOTCH signaling is linked to various human cancers.
  • Targeting NOTCH pathway components is an active area of cancer research.

Purpose of the Study:

  • To review recent advances in understanding HES6, a less-studied NOTCH pathway component.
  • To summarize the role of HES6 in cancer, particularly uveal melanoma.
  • To discuss current strategies for targeting the NOTCH-HES6 axis in cancer treatment.

Main Methods:

  • Literature review of recent research on HES6 and NOTCH signaling.
  • Analysis of HES6's role in cancer pathogenesis.
  • Examination of therapeutic approaches targeting the NOTCH-HES6 pathway.

Main Results:

  • HES6 is an emerging player in the NOTCH pathway with implications in cancer.
  • Specific roles of HES6 in uveal melanoma development are being elucidated.
  • The NOTCH-HES6 axis presents a potential therapeutic target.

Conclusions:

  • Further research into HES6 is needed to fully understand its function in cancer.
  • Targeting the NOTCH-HES6 pathway holds promise for novel cancer therapies.
  • HES6 represents a potential biomarker and therapeutic target in oncology.
Keywords:
HES6NOTCHcancerssignalinguveal melanoma

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

534
An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues10:41

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

Published on: April 5, 2018

10.5K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.2K